Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
213 Use of A novel peptide ligand targeting multiple immune checkpoints: a novel approach to immunotherapy against central nervous system tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.
